Back to news archive
Image for QuickMIC® rapid AST study with East-Tallinn Central Hospital in Estonia
News 2022-10-16

QuickMIC® rapid AST study with East-Tallinn Central Hospital in Estonia

The clinical microbiology laboratory at the East-Tallinn Central Hospital in Estonia is running a performance study with our newly CE-marked QuickMIC system for rapid AST. The laboratory team is headed by Dr Marina Ivanova, also Estonia representative to the EUCAST General Committee. “I had the opportunity to visit the East-Tallinn Central Hospital and the team of Marina already at the beginning of our development phase of QuickMIC to collect valuable market input. I got very impressed already at my first visit and we have got to know this team and the clinical laboratory for working very committedly in the fore-front of optimising work-flows for best clinical output. We highly value our continued collaboration”, says Dr Sara Thorslund, CEO of Gradientech.

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2023 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book